Skip to Main Content

Dr. Peter Stock is a transplant surgeon who specializes in kidney, liver and pancreas transplants. He is co-director of the Pancreatic Islet Cell Transplantation Program.

In his research, Stock studies body mechanisms that lead to transplant rejection when the donor and recipient are not genetically identical. He also studies chimerism (a therapy to prevent transplant rejection that uses the donor's bone marrow cells) and pancreatic islet cell transplantation (a procedure that can allow people with type 1 diabetes to discontinue insulin therapy).

Stock received his medical training at the University of Minnesota, completing a surgical residency before coming to UCSF for a transplant fellowship. He joined the UCSF faculty in 1992.

Stock is an active teacher and supervises surgical residents and fellows. He is a member of numerous professional and honorary societies.

  • Board Certifications

    American Board of Surgery, Surgery, 1991

  • Fellowships

    UCSF, Transplant Surgery, 1992

  • Internship

    University of Minnesota, General Surgery, 1990

  • Education

    University of Illinois College of Medicine, 1982

  • Languages

    English

Where I see patients (3)

    My reviews

    4.8

    Overall Experience
    69 Ratings
    About our process
    Mar 25, 2025
    I have had a fair experience.
    Jan 16, 2025
    I had a great experience, have only Good remarks about my experience
    Jan 08, 2025
    Good
    Sep 25, 2024
    Dr. PETE STOCK spent almost an hour with me to solve all my entire health issues and problems. He had a very good patience to listen to all my questions, concerns, problems and issues regarding my Transplanted Liver, my troubles kidney's warning signs, my stomach issues with aching, 4 months missing for monthly Liver function tests, loss lot of weight, extreme chronic fatigue symptoms issues, extreme low immune function symptoms, and under nutrition issues with no appetite as well as difficulty to fall asleep at night. He is the only Doctor or surgeon willing to pay attention to patient's disease warning signs, health conditions with concerns, health issues needing, and promising following up treatment for the specific disease test results. He instructed me to write down his command orders in a list and instructed to contact PA name DANA to follow his command orders list. He is the only Doctor spent this kind patience and time with me. He did really care for my entire health. He told me that I could live longer than average Liver Transplant patients. He is my doctor HERO. He did the best job for my Liver Transplant . He is the best surgeon in UCSF HOSPITAL history. I wish him the best in his profession and had a long life to continue to help others patients. God bless him.
    Sep 17, 2024
    Very excellent job
    Aug 25, 2024
    Dr. Stock and Giulia Warner are the very best!
    Jun 04, 2024
    He explains the entire treatment process very well and listens to the patient calmly and answers the patient's questions.
    Mar 06, 2024
    Good
    Mar 06, 2024
    All good .
    Dec 04, 2023
    Great job from everyone
    Dec 01, 2023
    The Doctor was great Ty
    Oct 31, 2023
    Very personable. Good listener
    Oct 25, 2023
    My visit provided in depth discussion about my health and wellness with my physician. My overall test results were good and I was also able to see my liver transplant surgeon for the first time in several years.
    Sep 02, 2023
    Good
    Aug 30, 2023
    Excellent
    Aug 16, 2023
    It was ah awesome visit. All problems were discussed and answered.
    Jul 15, 2023
    My concerns were wholly addressed. Overall a comfortable informative visit.
    Decorative Caduceus

    Parathyroid Allotransplant for Treatment of Hypoparathyroidism

    The primary efficacy endpoint is attainment of levels of intact PTH that are in the normal target range and at least a doubling of the baseline intact PTH level prior to transplantation

    Recruiting

    Share